Navigation Links
Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals
Date:8/14/2014

nts. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in roughly 65 countries. The company's fiscal 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

Forward-Looking Statements
Statements in this document that are not strictly historical, including statements regarding the Questcor acquisition, future financial and operating results, benefits and synergies of the transaction, future opportunities for the combined businesses and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, and involve a number of risks and uncertainties. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include risks and uncertainties related to, among other things: general economic conditions and conditions affecting the industries in which Mallinckrodt and Questcor operate; the commercial success of Mallinckrodt's and Questcor's products, including H.P. Acthar® Gel ("Acthar"); Mallinckrodt's and Questcor's ability to protect intellectual property rights; Mallinckrodt's ability to successfully integrate Questcor's operations and employees with Mallinckrodt's existing business; the ability to realize anticipated growth, synergies and cost savings; Questcor's performance and maintenance of important business relationships; the lack of patent protection for Acthar, and the possible United States Food and Drug Administration ("FDA") approval and market introduction of additional competitive products; Q
'/>"/>

SOURCE Mallinckrodt plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
2. Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction
3. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
5. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
6. CryoLife Completes Acquisition of Hemosphere
7. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
8. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
9. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
10. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
11. Ablative Solutions Completes $5.3M Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Pa. , Aug. 31, 2015  The departments ... an event today at Gaudenzia Concept 90 to raise ... drug overdose crisis in Pennsylvania ... treatment and focus on recovery through the Building ... many Pennsylvanians are dying every day to a disease ...
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, 2015 ... SAN) and the life sciences team at Google announced ... outcomes for people with type 1 and type 2 ... devices with Google,s expertise in analytics, miniaturized electronics and ... to improve diabetes care by developing new tools that ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... Masimo (Nasdaq: MASI ) announced ... Welfare (MHLW) regulatory clearance of its noninvasive and ... the Masimo rainbow SET® platform.  Representing a breakthrough ... hemoglobin level in real-time, SpHb tracks and trends ...
... As US doctors consider the switch from paper charts to ... have teamed up to provide an absolutely free EMR ... only ad-supported EMR platform for medical providers in a sector ... for a five provider practice in the first year. Since ...
Cached Medicine Technology:Masimo Noninvasive and Continuous Hemoglobin Receives Market Clearance in Japan 2Masimo Noninvasive and Continuous Hemoglobin Receives Market Clearance in Japan 3Masimo Noninvasive and Continuous Hemoglobin Receives Market Clearance in Japan 4Can an Ad-Supported EMR Fuel Healthcare's Technology Revolution? 2Can an Ad-Supported EMR Fuel Healthcare's Technology Revolution? 3Can an Ad-Supported EMR Fuel Healthcare's Technology Revolution? 4
(Date:9/1/2015)... ... September 01, 2015 , ... ... retailer of professional hair salons. This highly anticipated partnership between Curly Hair Solutions™ ... Keeper™ Styling Collection. Founder Jonathan Torch and the Curly Hair Solutions™ team could ...
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry is an ... for physical therapy patients. The Registry is being developed by the American Physical Therapy ... are happy to be selected to contribute FOTO Outcomes measures as one of the ...
(Date:8/31/2015)... GA (PRWEB) , ... August 31, 2015 , ... ... to the healthcare industry, released their latest predictive use case focused on helping ... Purchasing Program (HVBP). Under this program, hospital payments are adjusted based on performance ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... giving potential patients the resources they need to have a successful cosmetic procedure; ... certified plastic surgeons; Cosmetic Town Journal is always ready to help. , It ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... (WDI) at Western University of Health Sciences to learn more about its integrated ... School of Dental Sciences and Institute of Cellular Medicine at Newcastle University, and ...
Breaking Medicine News(10 mins):Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4
... Reporter , MONDAY, Aug. 9 (HealthDay News) -- The onset of ... as young as 7 and 8 now showing the beginnings of ... -- long linked to earlier sexual development -- may be to ... ages 6 to 8 from Cincinnati, East Harlem, N.Y. and San ...
... oral cancer, which a dentist could perform by simply using ... set to be developed by researchers at the University of ... The international research team, involving scientists in Sheffield, has been ... to develop the test, which could provide an accurate diagnosis ...
... been found for the first time outside of the hippocampus ... Norwegian University of Science and Technology (NTNU). The finding should ... internal maps that help us remember where we have been ... Five years ago, researchers at NTNU,s Kavli Institute for ...
... drug to the standard treatment regimen for hepatitis C significantly ... patients, according to a research report published Monday in the ... The research team, led by Paul Kwo, M.D., of Indiana ... doubled the treatment,s effectiveness when given for 48 weeks in ...
... By Dennis Thompson HealthDay Reporter , FRIDAY, ... noted American pediatric endocrinologist and researcher of what they ... bisexuality in the womb in a dispute that has ... revolve around the experimental prenatal treatment of female fetuses ...
... 2010) - While many see no downside to being beautiful, ... says attractive women face discrimination when it comes to landing ... in the May/June Journal of Social Psychology , Stefanie ... found that beauty has an ugly side, at least for ...
Cached Medicine News:Health News:Many Girls Now Begin Puberty at Age 7, 8 2Health News:Many Girls Now Begin Puberty at Age 7, 8 3Health News:New 'dentist' test to detect oral cancer will save lives 2Health News:New 'dentist' test to detect oral cancer will save lives 3Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 2Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 3Health News:Ethicists Charge Doctor With Trying to Prevent Homosexuality in the Womb 2Health News:Ethicists Charge Doctor With Trying to Prevent Homosexuality in the Womb 3Health News:Ethicists Charge Doctor With Trying to Prevent Homosexuality in the Womb 4Health News:UC Denver study finds beautiful women face discrimination in certain jobs 2
Hemagglutination slide test for the qualitative and quantitative detection of Rheumatoid Factor in serum or synovial fluid....
Hemagglutination slide test for the differential qualitative detection and quantitative determination of infectious mononucleosis and other heterophile antibodies in serum or plasma....
Color-enhanced hemagglutination slide test for the rapid qualitative and semi-quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
Medicine Products: